OmniAb, Inc.
Antibody discovery platform and services using proprietary phage display and immunization technologies
- Sector
- Biotech
- Headquarters
- EMERYVILLE, CA
- Founded
- 2022
- Latest Form D
- $30M, Sep 2025
- Total capital
- $30M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $30M
- 1 Form D · last Sep 2025
- 13 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 21 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$30M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Carolyn R. BertozziDirectorNamed in SEC Form D filings
- Charles W. BerkmanExecutive OfficerNamed in SEC Form D filings
- Jennifer W. CochranDirectorNamed in SEC Form D filings
- John W. HigginsDirectorNamed in SEC Form D filings
- Kurt W. GustafsonExecutive OfficerNamed in SEC Form D filings
- Matthew W. FoehrExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
- Philip J. GotwalsDirectorNamed in SEC Form D filings
- Steve R. CrouseDirectorNamed in SEC Form D filings
- Steve R. LoveDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 21- PendingScreening Platform For Bispecific AntibodiesUSPTOApplication PCTUS2025061027
- PendingCompositions And Methods For Library PreparationUSPTOApplication PCTUS2025058736
- PendingHeteroarylindole Inhibitors Of APOL-1USPTOApplication PCTUS2025026857
Show all 21 patent records
- Screening Platform For Bispecific AntibodiesApplication PCTUS2025061027Pending
- Compositions And Methods For Library PreparationApplication PCTUS2025058736Pending
- Heteroarylindole Inhibitors Of APOL-1Application PCTUS2025026857Pending
- Screening Platform For Bispecific AntibodiesApplication 63738366Pending
- Polypeptides That Bind To NKP46Application PCTUS2024061436Pending
- Compositions And Methods For Library PreparationApplication 63733936Pending
- Camelizing Amino Acid SubstitutionsApplication 63717253Pending
- Polypeptide that Binds to NKp46Application 63687275Pending
- Polypeptide That Binds To NKP46Application 63666374Pending
- Tetracyclic Compounds Containing A Fused Indole For Treating APOL1-MEDIATED Chronic Kidney DiseaseApplication PCTUS2024034465Pending
- Heteroarylindole Inhibitors Of APOL-1Application PCTUS2024027287Pending
- Heteroarylindole Inhibitors Of APOL-1Application 63641303Pending
- Polypeptide that Binds to NKp46Application 63613034Pending
- Antibodies For Zika VirusApplication PCTUS2023083586Pending
- Tetracyclic Compounds Containing A Fused Indole For Treating APOL1-MEDIATED Chronic Kidney DiseaseApplication 63524176Pending
- Heteroarylindole Inhibitors Of APOL-1Application 63463854Pending
- Antibodies For Zika VirusApplication 63480899Pending
- Tetracyclic Compounds Containing A Fused Indole For Treating APOL1-MEDIATED Chronic Kidney DiseaseApplication 19494735Pending
- Heteroarylindole Inhibitors Of APOL-1Application 19480304Pending
- Antibodies For Zika VirusApplication 19147638Pending
- Polypeptides That Bind To NKP46Application 19588789Pending
Related companies, and why
- Dimension Inx Corp.Similar federal contract value in Biotech · null in contracts
- Scienture Inc.Similar federal contract value in Biotech · null in contracts
- LABGENIUS LtdSimilar federal contract value in Biotech · null in contracts
- DepYmed Inc.Similar federal contract value in Biotech · null in contracts
- SmartCells, IncSimilar federal contract value in Biotech · null in contracts
- Halodine LLCSimilar federal contract value in Biotech · null in contracts
Press
Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vague FierceBiotech
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .